Patient reported outcomes of new brand-generic product of Teriflunomide (TEBAZIO®) in patients with relapsing-remitting multiple sclerosis: Preliminary analysis
2019 ◽
Vol Volume 10
◽
pp. 373-384
◽
2019 ◽
Vol 5
(4)
◽
pp. 205521731988719
◽
2017 ◽
Vol 11
◽
pp. 18-24
◽